Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica

References

• KimMSKimJSParkHJChoWKChaKHHwangSJEnhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent processInt J Nanomedicine201162997300922162657
   PubMed Web of Science ®Google Scholar
• AbdullahGZAbdulkarimMFSalmanIMIn vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical deliveryInt J Nanomedicine2011638739621499428
   PubMed Web of Science ®Google Scholar
• Merisko-LiversidgeELiversidgeGGCooperERNanosizing: a formulation approach for poorly-water-soluble compoundsEur J Pharm Sci200318211312012594003
   PubMed Web of Science ®Google Scholar
• SongWYuXWWangSXCyclodextrin-erythromycin complexes as a drug delivery device for orthopedic applicationInt J Nanomedicine201163173318622228990
   PubMed Web of Science ®Google Scholar
• Vallet-RegiMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed Engl200746407548755817854012
   PubMed Web of Science ®Google Scholar
• KresgeCLeonowiczMRothWVartuliJBeckJOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanismNature19923596397710712
   Web of Science ®Google Scholar
• ZhaoDFengJHuoQTriblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom poresScience199827953505485529438845
   PubMed Web of Science ®Google Scholar
• Vallet-RegiMRamilaAdel RealRPPerez-ParienteJA new property of MCM-41: drug delivery systemChem Mater2001132308311
   Web of Science ®Google Scholar
• ChenBWangZQuanGIn vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulationInt J Nanomedicine2012719920922275835
   PubMed Web of Science ®Google Scholar
• CaoXDengWWFuMIn vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticlesInt J Nanomedicine2012775376222393284
   PubMed Web of Science ®Google Scholar
• LiuQZhangJSunWXieQRXiaWGuHDelivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mes-oporous silica nanoparticles to inhibit cancer cellsInt J Nanomedicine20127999101322403484
   PubMed Web of Science ®Google Scholar
• ZhangYZZhiZZJiangTYZhangJHWangZYWangSLSpherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartanJ Control Release2010145325726320450945
   PubMed Web of Science ®Google Scholar
• Van SpeybroeckMBarillaroVThiTDOrdered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugsJ Pharm Sci20099882648265819072861
   PubMed Web of Science ®Google Scholar
• ZhangYJiangTZhangQWangSInclusion of telmisartan in meso-cellular foam nanoparticles: drug loading and release propertyEur J Pharm Biopharm2010761172320685333
   PubMed Web of Science ®Google Scholar
• Van SpeybroeckMMellaertsRMolsREnhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silicaEur J Pharm Sci201041562363020850527
   PubMed Web of Science ®Google Scholar
• MellaertsRMolsRJammaerJAIncreasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaEur J Pharm Biopharm200869122323018164930
   PubMed Web of Science ®Google Scholar
• WuZJiangYKimTLeeKEffects of surface coating on the controlled release of vitamin B1 from mesoporous silica tabletsJ Control Release2007119221522117434225
   PubMed Web of Science ®Google Scholar
• AmbrogiVPerioliLMarmottiniFMorettiMLolliniERossiCChlorhexidine MCM-41 mucoadhesive tablets for topical useJ Pharm Innov200944156164
   Web of Science ®Google Scholar
• XuWJGaoQXuYWuDSunYHpH-controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalateMater Res Bull2009443606612
   Web of Science ®Google Scholar
• LimnellTSantosHAMakilaEDrug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methodsJ Pharm Sci201110083294330621520084
   PubMed Web of Science ®Google Scholar
• VialpandoMAertsAPersoonsJMartensJVan Den MooterGEvaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug releaseJ Pharm Sci201110083411342021387318
   PubMed Web of Science ®Google Scholar
• KiekensFEelenSVerheydenLDaemsTMartensJVan Den MooterGUse of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogsJ Pharm Sci201210131136114422190350
   PubMed Web of Science ®Google Scholar
• Dukić-OttARemonJPForemanPVervaetCImmediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisationEur J Pharm Biopharm200767371572417537625
   PubMed Web of Science ®Google Scholar
• HarrisMRGhebre-SellassieIFormulation variablesGhebre-SellassieIPharmaceutical Pelletization TechnologyNew York, NYMarcel Dekker1989
   Google Scholar
• PintoJBucktonGNewtonJThe influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisationInt J Pharm1982831187196
   Google Scholar
• SethiaSSquillanteEPhysicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation methodJ Pharm Sci20029191948195712210042
   PubMed Web of Science ®Google Scholar
• AmidonGLLennernasHShahVPCrisonJRA theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailabilityPharm Res19951234134207617530
   PubMed Web of Science ®Google Scholar
• MooreJWFlannerHHMathematical comparison of dissolution profilesPharm Technol19962066474
   Google Scholar
• KatiyarAYadavSSmirniotisPGPintoNGSynthesis of ordered large pore SBA-15 spherical particles for adsorption of biomoleculesJ Chromatogr A200611221–2132016716334
   PubMed Web of Science ®Google Scholar
• YuHZhaiQZMesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipineMicroporous Mesoporous Mater20091231–3298305
   Web of Science ®Google Scholar
• LeiJFanJYuCZImmobilization of enzymes in mesoporous materials: controlling the entrance to nanospaceMicroporous Mesoporous Mater2004733121128
   Web of Science ®Google Scholar
• KapoorSHegdeRBhattacharyyaAJInfluence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug releaseJ Control Release20091401343919654029
   PubMed Web of Science ®Google Scholar
• SalonenJLaitinenLKaukonenAMMesoporous silicon microparticles for oral drug delivery: loading and release of five model drugsJ Control Release20051082–336237416169628
   PubMed Web of Science ®Google Scholar
• LiuXLuMGuoZHuangLFengXWuCImproving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusionPharm Res201229380681722009589
   PubMed Web of Science ®Google Scholar
• TangQLXuYWuDStudies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug deliveryJ Control Release20061141414616784793
   PubMed Web of Science ®Google Scholar
• HanHCHuSFengJQGaoHLEffect of stearic acid, zinc stearate coating on the properties of synthetic hydromagnesiteAppl Surf Sci2011257726772682
   Web of Science ®Google Scholar
• OtsukaMGaoJMatsudaYEffect of amount of added water during extrusion-spheronization process on pharmaceutical properties of granulesDrug Dev Ind Pharm1994201929772992
   Web of Science ®Google Scholar
• EmamiJIn vitro-in vivo correlation: from theory to applicationsJ Pharm Pharm Sci20069216918916959187
   PubMed Web of Science ®Google Scholar